XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 23,693 $ 41,134
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 180,256 163,112
Accretion of loan discounts and premiums, net (6,015) (6,918)
Amortization of deferred financing costs, net 2,727 2,070
Stock compensation expense 6,826 6,128
Loss on impairment (gain on sale) of real estate assets, net 11,344 (11,066)
Loss (gain) on extinguishment of debt 67 (203)
Amortization related to derivative instruments 750 907
Non-cash casualty losses 537 3,299
Equity in (income) loss from investments in unconsolidated real estate entities (8,663) 2,382
Other non-cash loss 103 1
Changes in assets and liabilities:    
Other assets (9,910) (10,753)
Accounts payable and accrued expenses 19,275 8,404
Accrued interest payable 1,635 (1,059)
Other liabilities (666) (1,119)
Cash flow provided by operating activities 221,959 196,319
Cash flows from investing activities:    
Acquisition of real estate properties (152,748) (81,220)
Investments in unconsolidated real estate entities (24,412) (8,881)
Proceeds from dispositions of real estate properties, net 109,204 390,817
Capital expenditures (101,373) (92,057)
Real estate development expenditures (16,270) (41,894)
Proceeds from insurance claims 1,539 4,028
Cash flow (used in) provided by investing activities (152,975) 170,943
Return of investment in unconsolidated real estate entities 31,085 150
Cash flows from financing activities:    
Proceeds (costs) from issuance of common stock, net 150,713 (447)
Proceeds from unsecured revolver 398,416 239,000
Unsecured revolver and secured credit facility repayments (386,845) (282,652)
Mortgage principal repayments and payoffs (97,406) (211,064)
Payment for deferred financing costs (6,223) (437)
Distributions on common stock (113,801) (108,064)
Distributions to noncontrolling interests (2,912) (2,852)
Payment for debt extinguishment 0 (663)
Repurchase of shares related to equity award tax withholding (3,449) (2,572)
Cash flow used in financing activities (61,507) (369,751)
Net change in cash and cash equivalents, and restricted cash 7,477 (2,489)
Cash and cash equivalents, and restricted cash, beginning of period 43,452 50,732
Cash and cash equivalents, and restricted cash, end of the period 50,929 48,243
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 23,290 17,611
Restricted Cash 27,639 30,632
Total cash, cash equivalents, and restricted cash, end of period $ 50,929 $ 48,243